A citation-based method for searching scientific literature

M M van der Klauw, B H R Wolffenbuttel. Neth J Med 2012
Times Cited: 7







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
389
42


Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
28

One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.
Julio Rosenstock, Helena W Rodbard, Stephen C Bain, David D'Alessio, Jochen Seufert, Anne B Thomsen, Claus Bo Svendsen, J Hans DeVries. J Diabetes Complications 2013
33
28

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
S E Inzucchi, R M Bergenstal, J B Buse, M Diamant, E Ferrannini, M Nauck, A L Peters, A Tsapas, R Wender, D R Matthews. Diabetologia 2012
975
28

Exenatide therapy in insulin-treated type 2 diabetes and obesity.
U A Nayak, J Govindan, V Baskar, D Kalupahana, B M Singh. QJM 2010
48
28

Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.
Sabine Arnolds, Sibylle Dellweg, Janina Clair, Marie-Paule Dain, Michael A Nauck, Klaus Rave, Christoph Kapitza. Diabetes Care 2010
139
28


Glucagon-like peptide analogues for type 2 diabetes mellitus.
Deepson S Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh, Alisa Snaith. Cochrane Database Syst Rev 2011
149
28

Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*.
K Y Thong, B Jose, N Sukumar, M L Cull, A P Mills, T Sathyapalan, W Shafiq, A S Rigby, C Walton, R E J Ryder. Diabetes Obes Metab 2011
59
28

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.
Tina Vilsbøll, Mikkel Christensen, Anders E Junker, Filip K Knop, Lise Lotte Gluud. BMJ 2012
505
28

The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetes.
Antonio Ceriello, Katherine Esposito, Roberto Testa, Anna Rita Bonfigli, Maurizio Marra, Dario Giugliano. Diabetes Care 2011
91
14

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
Katherine Esposito, Francesco Nappo, Raffaele Marfella, Giovanni Giugliano, Francesco Giugliano, Myriam Ciotola, Lisa Quagliaro, Antonio Ceriello, Dario Giugliano. Circulation 2002
14

A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy.
Anand K Annamalai, Alison Webb, Narayanan Kandasamy, Maysoon Elkhawad, Samantha Moir, Fakhar Khan, Kaisa Maki-Petaja, Emma L Gayton, Christopher H Strey, Samuel O'Toole,[...]. J Clin Endocrinol Metab 2013
87
14

Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Hisko Oeseburg, Rudolf A de Boer, Hendrik Buikema, Pim van der Harst, Wiek H van Gilst, Herman H W Silljé. Arterioscler Thromb Vasc Biol 2010
175
14

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy.
L Monnier, C Colette, E Mas, F Michel, J P Cristol, C Boegner, D R Owens. Diabetologia 2010
100
14

The cardiovascular effects of GLP-1 receptor agonists.
Theodore Okerson, Robert J Chilton. Cardiovasc Ther 2012
88
14

The effect of acute hyperglycaemia on QTc duration in healthy man.
R Marfella, F Nappo, L De Angelis, M Siniscalchi, F Rossi, D Giugliano. Diabetologia 2000
123
14


Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress.
A Ceriello, F Mercuri, L Quagliaro, R Assaloni, E Motz, L Tonutti, C Taboga. Diabetologia 2001
315
14

Oxidative stress and diabetic complications.
Ferdinando Giacco, Michael Brownlee. Circ Res 2010
14

Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome.
Manfredi Tesauro, Francesca Schinzari, Angelo Adamo, Valentina Rovella, Francesca Martini, Nadia Mores, Angela Barini, Dario Pitocco, Giovanni Ghirlanda, Davide Lauro,[...]. Diabetes Care 2013
44
14


Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Thomas Nyström, Mark K Gutniak, Qimin Zhang, Fan Zhang, Jens Juul Holst, Bo Ahrén, Ake Sjöholm. Am J Physiol Endocrinol Metab 2004
482
14

Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects.
R Marfella, G Verrazzo, R Acampora, C La Marca, R Giunta, C Lucarelli, G Paolisso, A Ceriello, D Giugliano. Am J Physiol 1995
79
14

An update on oxidative stress-mediated organ pathophysiology.
Kahkashan Rashid, Krishnendu Sinha, Parames C Sil. Food Chem Toxicol 2013
78
14


Insulin as an anti-inflammatory and antiatherogenic modulator.
Paresh Dandona, Ajay Chaudhuri, Husam Ghanim, Priya Mohanty. J Am Coll Cardiol 2009
111
14


Glucagon-like peptide 1 reduces endothelial dysfunction, inflammation, and oxidative stress induced by both hyperglycemia and hypoglycemia in type 1 diabetes.
Antonio Ceriello, Anna Novials, Emilio Ortega, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Dario Giugliano, Stefano Genovese. Diabetes Care 2013
107
14

In vitro antimycoplasmal activity of oleuropein.
Pio Maria Furneri, Andreana Marino, Antonina Saija, Nicola Uccella, Giuseppe Bisignano. Int J Antimicrob Agents 2002
34
14


Comparison of a low-glycemic index vs standard diabetic diet.
Jakub Visek, Silvie Lacigova, Daniela Cechurova, Zdenek Rusavy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014
13
14

Waist circumference independently associates with the risk of insulin resistance and type 2 diabetes in mexican american families.
Manju Mamtani, Hemant Kulkarni, Thomas D Dyer, Laura Almasy, Michael C Mahaney, Ravindranath Duggirala, Anthony G Comuzzie, John Blangero, Joanne E Curran. PLoS One 2013
30
14

Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.
Y Mishima, A Kuyama, A Tada, K Takahashi, T Ishioka, M Kibata. Diabetes Res Clin Pract 2001
124
14


The anti-atherosclerotic effect of olive leaf extract is related to suppressed inflammatory response in rabbits with experimental atherosclerosis.
Lihui Wang, Chengyan Geng, Liping Jiang, Dezheng Gong, Dayu Liu, Hiroyuki Yoshimura, Laifu Zhong. Eur J Nutr 2008
52
14

New possibilities for the valorization of olive oil by-products.
Miguel Herrero, Temirkhon N Temirzoda, Antonio Segura-Carretero, Rosa Quirantes, Merichel Plaza, Elena Ibañez. J Chromatogr A 2011
48
14

HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
Enzo Bonora, Gianni Formentini, Francesco Calcaterra, Simonetta Lombardi, Franco Marini, Luciano Zenari, Francesca Saggiani, Maurizio Poli, Sandro Perbellini, Andrea Raffaelli,[...]. Diabetes Care 2002
360
14

Luteolin inhibits inflammatory response and improves insulin sensitivity in the endothelium.
Zhu Deqiu, Liu Kang, Yi Jiali, Liu Baolin, Liu Gaolin. Biochimie 2011
36
14

Inflammatory mechanisms in the regulation of insulin resistance.
Herbert Tilg, Alexander R Moschen. Mol Med 2008
455
14

Effects of olive leaf polyphenols against H₂O₂ toxicity in insulin secreting β-cells.
Ahmet Cumaoğlu, Lucia Rackova, Milan Stefek, Murat Kartal, Pierre Maechler, Cimen Karasu. Acta Biochim Pol 2011
36
14





Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
Kazim Sahin, Muhittin Onderci, Mehmet Tuzcu, Bilal Ustundag, Gurkan Cikim, Ibrahim H Ozercan, Vidyasagar Sriramoju, Vijaya Juturu, James R Komorowski. Metabolism 2007
94
14


Hypertriglyceridemic hyperapoB in type 2 diabetes.
Allan D Sniderman, Benoit Lamarche, Jessica Tilley, David Seccombe, Jiri Frohlich. Diabetes Care 2002
42
14

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
Dongsheng Cai, Minsheng Yuan, Daniel F Frantz, Peter A Melendez, Lone Hansen, Jongsoon Lee, Steven E Shoelson. Nat Med 2005
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.